Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease
- PMID: 30160975
- DOI: 10.2214/AJR.17.19155
Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease
Abstract
Objective: The purpose of this article is to study the effect of the administration of multiple IV doses of gadolinium-based contrast agent on the intrinsic T1 hyperintensity in the dentate nucleus and globus pallidus in patients with multiple sclerosis (MS).
Materials and methods: A retrospective review of imaging in patients with relapsing-remitting MS was performed. Images of 20 patients who received four or more doses of gadolinium-based contrast agent were reviewed. Patients received the linear agent gadopentetate dimeglumine before 2011 and the macrocyclic agent gadobutrol from 2011 onward. Dentate nucleus-to-pons and globus pallidus-to-thalamus signal intensity (SI) ratios were evaluated. SI ratios were compared over time with multiple injections of gadolinium. Similar SI ratios were evaluated for six patients who received gadopentetate dimeglumine and then underwent multiple subsequent MRI studies without contrast agent administration.
Results: The increase in the dentate nucleus-to-pons SI ratio after multiple administrations of the linear agent gadopentetate dimeglumine (mean = 1.44; SD = 2.50) was significantly higher than that with the macrocyclic agent gadobutrol (mean = -0.11; SD = 2.33) (p < 0.001). The globus pallidus-to-thalamus and dentate nucleus-to-CSF ratios also increased with multiple contrast injections over time, but the changes were not found to be statistically significant. The increase in SI in the dentate nucleus was not observed in patients who stopped receiving contrast injections, after showing a previous increase over time with gadolinium.
Conclusion: In patients with MS, SI within the dentate nucleus and globus pallidus increased on unenhanced T1-weighted images and was significantly greater with the administration of a linear agent than with a macrocyclic agent. This increase in SI over time is likely a reflection of gadolinium deposition and not due to intrinsic disease, as previously postulated.
Keywords: MRI; dentate nucleus; gadolinium; multiple sclerosis; signal intensity.
Similar articles
-
Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.Eur Radiol. 2016 Mar;26(3):807-15. doi: 10.1007/s00330-015-3879-9. Epub 2015 Jun 25. Eur Radiol. 2016. PMID: 26105022
-
Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol.AJR Am J Roentgenol. 2016 Feb;206(2):414-9. doi: 10.2214/AJR.15.15327. Epub 2015 Dec 23. AJR Am J Roentgenol. 2016. PMID: 26700156
-
Comparison of Unenhanced T1-Weighted Signal Intensities Within the Dentate Nucleus and the Globus Pallidus After Serial Applications of Gadopentetate Dimeglumine Versus Gadobutrol in a Pediatric Population.Invest Radiol. 2018 Feb;53(2):119-127. doi: 10.1097/RLI.0000000000000419. Invest Radiol. 2018. PMID: 28976476
-
Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.Neuroradiology. 2016 May;58(5):433-41. doi: 10.1007/s00234-016-1658-1. Epub 2016 Feb 12. Neuroradiology. 2016. PMID: 26873830 Review.
-
Ten years of gadolinium retention and deposition: ESMRMB-GREC looks backward and forward.Eur Radiol. 2024 Jan;34(1):600-611. doi: 10.1007/s00330-023-10281-3. Epub 2023 Oct 7. Eur Radiol. 2024. PMID: 37804341 Free PMC article. Review.
Cited by
-
Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?Insights Imaging. 2019 Sep 4;10(1):82. doi: 10.1186/s13244-019-0767-x. Insights Imaging. 2019. PMID: 31482392 Free PMC article.
-
Dentate-nucleus gadolinium deposition on magnetic resonance imaging: ultrasonographic and clinical correlates in multiple sclerosis patients.Neurol Sci. 2022 Apr;43(4):2631-2639. doi: 10.1007/s10072-021-05702-4. Epub 2021 Nov 4. Neurol Sci. 2022. PMID: 34735650 Free PMC article.
-
Evaluation of the effect of multiple administrations of gadopentetate dimeglumine or gadoterate meglumine on brain T1-weighted hyperintensity in pediatric patients.Pediatr Radiol. 2021 Dec;51(13):2568-2580. doi: 10.1007/s00247-021-05134-4. Epub 2021 Jul 20. Pediatr Radiol. 2021. PMID: 34286351
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical